1. Home
  2. INDB vs ADPT Comparison

INDB vs ADPT Comparison

Compare INDB & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

SELL

Current Price

$79.26

Market Cap

4.0B

Sector

Finance

ML Signal

SELL

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

SELL

Current Price

$24.95

Market Cap

4.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
INDB
ADPT
Founded
1907
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
INDB
ADPT
Price
$79.26
$24.95
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
★ $93.43
$29.81
AVG Volume (30 Days)
416.7K
★ 2.3M
Earning Date
10-15-2026
11-04-2026
Dividend Yield
★ 3.32%
N/A
EPS Growth
N/A
★ 63.89
EPS
★ 3.33
N/A
Revenue
N/A
★ $276,976,000.00
Revenue This Year
$20.49
$5.94
Revenue Next Year
$4.88
$22.42
P/E Ratio
$23.15
★ N/A
Revenue Growth
N/A
★ 54.77
52 Week Low
$65.45
$12.00
52 Week High
$87.50
$30.74

Technical Indicators

Market Signals
Indicator
INDB
ADPT
Relative Strength Index (RSI) 52.65 37.90
Support Level $79.61 $23.73
Resistance Level $80.52 $26.51
Average True Range (ATR) 1.60 1.44
MACD 0.10 -0.49
Stochastic Oscillator 89.53 0.43

Price Performance

Historical Comparison
INDB
ADPT

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: